The present invention relates to novel compounds of formula (I) or detectably labeled compounds thereof, stereoisomers, racemic mixtures, pharma- ceutically acceptable salts, hydrates or solvates that can be used to image and determine the amount of alpha-
synuclein aggregates.Furthermore, the compounds can be used to diagnose diseases, disorders or disorders associated with alpha-
synuclein aggregates, including but not limited to Lewy bodies and / or Lewy neurites (e.g., Parkinson's
disease), to determine a predisposition to such diseases, disorders or disorders, to prognose such diseases, disorders or disorders, to monitor the progression of
disease in patients suffering from such diseases, disorders or disorders, to monitor the progression of such diseases, disorders or disorders, and to predict the responsiveness of patients suffering from such diseases, disorders or disorders to their treatment.